Evidence map›Paper›PMID 33885812›Full record

ArticleNucleic acids research2021

Estimation of peptide elongation times from ribosome profiling spectra.

Michael Y Pavlov, Gustaf Ullman, Zoya Ignatova, Måns Ehrenberg

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Michael Y PavlovDepartment of Cell and Molecular Biology, Biomedical Center, University of Uppsala, 75237 Uppsala, Sweden.ORCID 0000-0002-3794-1870
Gustaf UllmanDepartment of Cell and Molecular Biology, Biomedical Center, University of Uppsala, 75237 Uppsala, Sweden.
Zoya IgnatovaInstitute for Biochemistry & Molecular Biology, University of Hamburg, 20146 Hamburg, Germany.ORCID 0000-0002-9478-8825
Måns EhrenbergDepartment of Cell and Molecular Biology, Biomedical Center, University of Uppsala, 75237 Uppsala, Sweden.
Uppsala University · SEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome profiling spectra bear rich information on translation control and dynamics. Yet, due to technical biases in library generation, extracting quantitative measures of discrete translation events has remained elusive. Using maximum likelihood statistics and data set from Escherichia coli we develop a robust method for neutralizing technical biases (e.g. base specific RNase preferences in ribosome-protected mRNA fragments (RPF) generation), which allows for correct estimation of translation times at single codon resolution. Furthermore, we validated the method with available datasets from E. coli treated with antibiotic to inhibit isoleucyl-tRNA synthetase, and two datasets from Saccharomyces cerevisiae treated with two RNases with distinct cleavage signatures. We demonstrate that our approach accounts for RNase cleavage preferences and provides bias-corrected translation times estimates. Our approach provides a solution to the long-standing problem of extracting reliable information about peptide elongation times from highly noisy and technically biased ribosome profiling spectra.

Indexed as

Peptide Chain Elongation, TranslationalCodonEscherichia coliHigh-Throughput Nucleotide SequencingModels, GeneticRibonucleasesRibosomesSaccharomyces cerevisiaeSequence Analysis, RNACodonRibonucleases

Identifiers

PMID33885812
PMCPMC8136808
OpenAlexW3152843612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.